Genome maintenance and mutagenesis in embryonic stem cells

Cell Cycle

Volumn 5, Issue 23, 2006, Pages 2710-2714

  Lin, Qing ^a   Donahue, Sarah L ^a   Ruley, H Earl ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemical carcinogenesis; Chromosome stability; DNA repair; Gene traps; LOH; Stem cells

Indexed keywords

CARCINOGENESIS; CARCINOGENICITY; CHROMOSOMAL INSTABILITY; EMBRYONIC STEM CELL; GENE MUTATION; GENOME; HETEROZYGOSITY; HUMAN; MUTAGENESIS; NONHUMAN; REVIEW;

EID: 33845443764     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.23.3517     Document Type: Review

References (82)

1. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998; 396:643-9.
2. Loeb LA, Loeb KR, Anderson JP. Multiple mutations and cancer. Proc Natl Acad Sci USA 2003; 100:776-81.
3. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004; 432:338-41.
4. Stoler DL, Chen N, Basik M, Kahlenberg MS, Rodriguez-Bigas MA, Petrelli NJ, Anderson GR. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci USA 1999; 96:15121-6.
5. Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 2001; 61:818-22.
6. Luo L, Li B, Pretlow TP. DNA alterations in human aberrant crypt foci and colon cancers by random primed polymerase chain reaction. Cancer Res 2003; 63:6166-9.
7. Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Koprowicz KM, Bronner MP, Brentnall TA. DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free. Am J Pathol 2003; 162:665-72.
8. Lasko D, Cavenee W, Nordenskjold M. Loss of constitutional heterozygosity in human cancer. Annu Rev Genet 1991; 25:281-314.
9. Feinberg AP. The epigenetics of cancer etiology. Semin Cancer Biol 2004; 14:427-32.
10. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. A census of human cancer genes. Nat Rev Cancer 2004; 4:177-83.
11. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001; 411:366-74.
12. Risinger MA, Groden J. Crosslinks and crosstalk: Human cancer syndromes and DNA repair defects. Cancer Cell 2004; 6:539-45.
13. Loeb LA. A mutator phenotype in cancer. Cancer Res 2001; 61:3230-9.
14. Duesberg P, Fabarius A, Hehlmann R. Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells. IUBMB Life 2004; 56:65-81.
15. Sieber OM, Heinimann K, Tomlinson IP. Genomic instability-the engine of tumorigenesis? Nat Rev Cancer 2003; 3:701-8.
16. Donahue SL, Lin Q, Cao S, Ruley HE. Carcinogens induce genome-wide loss of heterozygosity in normal stem cells without persistent chromosomal instability. Proc Natl Acad Sci USA 2006; 103:11642-6.
17. Wicha MS, Liu S, Dontu G. Cancer stem cells: An old idea-a paradigm shift. Cancer Res 2006; 66:1883-90, (discussion 95-6).
18. Lin Q, Donahue SL, Mooore-Jarrett T, Cao S, Osipovich AB, Ruley HE. Mutagenesis of diploid mammalian genes by gene entrapment. Nucleic Acids Res 2006, (in press).
19. McCann J, Choi E, Yamasaki E, Ames BN. Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals. Proc Natl Acad Sci USA 1975; 72:5135-9.
20. Luch A. Nature and nurture - Lessons from chemical carcinogenesis. Nat Rev Cancer 2005; 5:113-25.
21. Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA. Environmental and chemical carcinogenesis. Semin Cancer Biol 2004; 14:473-86.
22. Vogel EW, Nivard MJ. Performance of 181 chemicals in a Drosophila assay predominantly monitoring interchromosomal mitotic recombination. Mutagenesis 1993; 8:57-81.
23. Wijnhoven SW, Kool HJ, van Teijlingen CM, van Zeeland AA, Vrieling H. Loss of heterozygosity in somatic cells of the mouse. An important step in cancer initiation? Mutat Res 2001; 473:23-36.
24. Turker MS. Autosomal mutation in somatic cells of the mouse. Mutagenesis 2003; 18:1-6.
25. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001; 411:390-5.
26. Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nat Genet 2003; 33(Suppl):238-44.
27. Wang TL, Rago C, Silliman N, Ptak J, Markowitz S, Willson JK, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE. Prevalence of somatic alterations in the colorectal cancer cell genome. Proc Natl Acad Sci USA 2002; 99:3076-80.
28. Kumar S, Subramanian S. Mutation rates in mammalian genomes. Proc Natl Acad Sci USA 2002; 99:803-8.
29. Nakayama H. RecQ family helicases: Roles as tumor suppressor proteins. Oncogene 2002; 21:9008-21.
30. Guo G, Wang W, Bradley A. Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells. Nature 2004; 429:891-5.
31. Yusa K, Horie K, Kondoh G, Kouno M, Maeda Y, Kinoshita T, Takeda J. Genome-wide phenotype analysis in ES cells by regulated disruption of Bloom's syndrome gene. Nature 2004; 429:896-9.
32. Girard L, Zochbauer-Muller S, Virmani AK, Gazdar AF, Minna JD. Genome-wide allelo-typing of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and nonsmall cell lung cancer, and loci clustering. Cancer Res 2000; 60:4894-906.
33. Devilee P, Cleton-Jansen AM, Cornelisse CJ. Ever since Knudson. Trends Genet 2001; 17:569-73.
34. Deng G, Lu Y, Zlotnikov G, Thor AD, Smith HS. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 1996; 274:2057-9.
35. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004; 4:448-56.
36. Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, Rabinovitch PS, Reid BJ. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 1999; 22:106-9.
37. van Tilborg AA, de Vries A, de Bont M, Groenfeld LE, van der Kwast TH, Zwarthoff EC. Molecular evolution of multiple recurrent cancers of the bladder. Hum Mol Genet 2000; 9:2973-80.
38. Roschke AV, Stover K, Tonon G, Schaffer AA, Kirsch IR. Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability. Neoplasia 2002; 4:19-31.
39. Masramon L, Vendrell E, Tarafa G, Capella G, Miro R, Ribas M, Peinado MA. Genetic instability and divergence of clonal populations in colon cancer cells in vitro. J Cell Sci 2006; 119:1477-82.
40. Morley AA. Mitotic recombination in mammalian cells in vivo. Mutat Res 1991; 250:345-9.
41. Lambert IB, Singer TM, Boucher SE, Douglas GR. Detailed review of transgenic rodent mutation assays. Mutat Res 2005; 590:1-280.
42. Wiktor-Brown DM, Hendricks CA, Olipitz W, Engelward BP. Age-dependent accumulation of recombinant cells in the mouse pancreas revealed by in situ fluorescence imaging. Proc Natl Acad Sci USA 2006; 103:11862-7.
43. Shoemaker AR, Luongo C, Moser AR, Marton LJ, Dove WF. Somatic mutational mechanisms involved in intestinal tumor formation in Min mice. Cancer Res 1997; 57:1999-2006.
44. Mollersen L, Vikse R, Andreassen A, Steffensen IL, Mikalsen A, Paulsen JE, Alexander J. Adenomatous polyposis coli truncation mutations in 2-amino-1-methyl-phenylimidazo[4,5-b]pyridine (PhIP)-induced intestinal tumours of multiple intestinal neoplasia mice. Mutat Res 2004; 557:29-40.
45. Wistuba II, Mao L, Gazdar AF. Smoking molecular damage in bronchial epithelium. Oncogene 2002; 21:7298-306.
46. Wiencke JK. DNA adduct burden and tobacco carcinogenesis. Oncogene 2002; 21:7376-91.
47. De Bont R, van Larebeke N. Endogenous DNA damage in humans: A review of quantitative data. Mutagenesis 2004; 19:169-85.
48. Sanchez-Cespedes M, Ahrendt SA, Piantadosi S, Rosell R, Monzo M, Wu L, Westra WH, Yang SC, Jen J, Sidransky D. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers. Cancer Res 2001; 61:1309-13.
49. Swede H, Bartos JD, Chen N, Shaukat A, Dutt SS, McQuaid DA, Natarajan N, Rodriguez-Bigas MA, Nowak NJ, Wiseman SM, Alrawi S, Brenner BM, Petrelli NJ, Cummings KM, Stoler DL, Anderson GR. Genomic profiles of colorectal cancers differ based on patient smoking status. Cancer Genet Cytogenet 2006; 168:98-104.
50. Cairns J. Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc Natl Acad Sci USA 2002; 99:10567-70.
51. Potten CS, Owen G, Booth D. Intestinal stem cells protect their genome by selective segregation of template DNA strands. J Cell Sci 2002; 115:2381-8.
52. Smith GH. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development 2005; 132:681-7.
53. Armakolas A, Klar AJ. Cell type regulates selective segregation of mouse chromosome 7 DNA strands in mitosis. Science 2006; 311:1146-9.
54. Cervantes RB, Stringer JR, Shao C, Tischfield JA, Stambrook PJ. Embryonic stem cells and somatic cells differ in mutation frequency and type. Proc Natl Acad Sci USA 2002; 99:3586-90.
55. Aladjem MI, Spike BT, Rodewald LW, Hope TJ, Klemm M, Jaenisch R, Wahl GM. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol 1998; 8:145-55.
56. 1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc Natl Acad Sci USA 2004; 101:14443-8.
57. Saretzki G, Armstrong L, Leake A, Lako M, von Zglinicki T. Stress defense in murine embryonic stem cells is superior to that of various differentiated murine cells. Stem Cells 2004; 22:962-71.
58. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: Induction, repair and significance. Mutat Res 2004; 567:1-61.
59. Turner DR, Dreimanis M, Holt D, Firgaira FA, Morley AA. Mitotic recombination is an important mutational event following oxidative damage. Mutat Res 2003; 522:21-6.
60. Wang Y, Erdmann N, Giannone RJ, Wu J, Gomez M, Liu Y. An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres. Proc Natl Acad Sci USA 2005; 102:10256-60.
61. Desmaze C, Soria JC, Freulet-Marriere MA, Mathieu N, Sabatier L. Telomere-driven genomic instability in cancer cells. Cancer Lett 2003; 194:173-82.
62. Damelin M, Sun YE, Sodja VB, Bestor TH. Decatenation checkpoint deficiency in stem and progenitor cells. Cancer Cell 2005; 8:479-84.
63. Longo L, Bygrave A, Grosveld FG, Pandolfi PP. The chromosome make-up of mouse embryonic stem cells is predictive of somatic and germ cell chimaerism. Transgenic Res 1997; 6:321-8.
64. Liu X, Wu H, Loring J, Hormuzdi S, Disteche CM, Bornstein P, Jaenisch R. Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev Dyn 1997; 209:85-91.
65. Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K, Sui G, Cutler DJ, Liu Y, Brimble SN, Noaksson K, Hyllner J, Schulz TC, Zeng X, Freed WJ, Crook J, Abraham S, Colman A, Sartipy P, Matsui S, Carpenter M, Gazdar AF, Rao M, Chakravarti A. Genomic alterations in cultured human embryonic stem cells. Nat Genet 2005; 37:1099-103.
66. Mortensen RM, Conner DA, Chao S, Geisterfer-Lowrance AA, Seidman JG. Production of homozygous mutant ES cells with a single targeting construct. Mol Cell Biol 1992; 12:2391-5.
67. Van Sloun PP, Wijnhoven SW, Kool HJ, Slater R, Weeda G, van Zeeland AA, Lohman PH, Vrieling H. Determination of spontaneous loss of heterozygosity mutations in Aprt heterozygous mice. Nucleic Acids Res 1998; 26:4888-94.
68. Chen Y, Yee D, Dains K, Chatterjee A, Cavalcoli J, Schneider E, Om J, Woychik RP, Magnuson T. Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells. Nat Genet 2000; 24:314-7.
69. Munroe RJ, Bergstrom RA, Zheng QY, Libby B, Smith R, John SW, Schimenti KJ, Browning VL, Schimenti JC. Mouse mutants from chemically mutagenized embryonic stem cells. Nat Genet 2000; 24:318-21.
70. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature 1998; 395:89-93.
71. Shao C, Stambrook PJ, Tischfield JA. Mitotic recombination is suppressed by chromosomal divergence in hybrids of distantly related mouse strains. Nat Genet 2001; 28:169-72.
72. Bertrand P, Saintigny Y, Lopez BS. p53's double life: Transactivation-independent repression of homologous recombination. Trends Genet 2004; 20:235-43.
73. Toueille M, Hubscher U. Regulation of the DNA replication fork: A way to fight genomic instability. Chromosoma 2004; 113:113-25.
74. Jiricny J. The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 2006; 7:335-46.
75. Stark JM, Jasin M. Extensive loss of heterozygosity is suppressed during homologous repair of chromosomal breaks. Mol Cell Biol 2003; 23:733-43.
76. Jensen-Seaman MI, Furey TS, Payseur BA, Lu Y, Roskin KM, Chen CF, Thomas MA, Haussler D, Jacob HJ. Comparative recombination rates in the rat, mouse, and human genomes. Genome Res 2004; 14:528-38.
77. Wijnhoven SW, Sonneveld E, Kool HJ, van Teijlingen CM, Vrieling H. Chemical carcinogens induce varying patterns of LOH in mouse T-lymphocytes. Carcinogenesis 2003; 24:139-44.
78. Little JB. Genomic instability and bystander effects: A historical perspective. Oncogene 2003; 22:6978-87.
79. Rugo RE, Almeida KH, Hendricks CA, Jonnalagadda VS, Engelward BP. A single acute exposure to a chemotherapeutic agent induces hyper-recombination in distantly descendant cells and in their neighbors. Oncogene 2005; 24:5016-25.
80. Bardelli A, Cahill DP, Lederer G, Speicher MR, Kinzler KW, Vogelstein B, Lengauer C. Carcinogen-specific induction of genetic instability. Proc Natl Acad Sci USA 2001; 98:5770-5.
81. Christmann M, Tomicic MT, Roos WP, Kaina B. Mechanisms of human DNA repair: An update. Toxicology 2003; 193:3-34.
82. Barnes DE, Lindahl T. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet 2004; 38:445-76.